Investigating combined treatment approaches for pediatric hepatoblastoma
Combined Modality Therapy in Hepatoblastoma: South Egypt Cancer Institute Experience
This study looks at how different treatment methods for liver cancer in children have worked in the past to help doctors understand what helps kids with hepatoblastoma do better.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 35 (estimated) |
| Ages | N/A to 18 Years |
| Sex | All |
| Sponsor | Assiut University Academic / other |
| Drugs / interventions | chemotherapy, doxorubicin |
| Locations | 1 site (Assiut) |
| Trial ID | NCT02557750 on ClinicalTrials.gov |
What this trial studies
This study aims to retrospectively analyze the effects of combined modality treatment on pediatric patients diagnosed with hepatoblastoma at the South Egypt Cancer Institute. It will review medical records from 2002 to 2016, focusing on patient demographics, clinical features, laboratory results, treatment courses, and outcomes. The research seeks to identify factors influencing prognosis and treatment efficacy in this population, contributing to a better understanding of hepatoblastoma management.
Who should consider this trial
Good fit: Ideal candidates for this study are pediatric patients under 19 years of age diagnosed with hepatoblastoma.
Not a fit: Patients over the age of 18 will not benefit from this study as they do not meet the eligibility criteria.
Why it matters
Potential benefit: If successful, this study could enhance treatment strategies and improve outcomes for children with hepatoblastoma.
How similar studies have performed: Other studies have shown success with combined modality treatments in pediatric oncology, indicating that this approach is supported by existing evidence.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients whose age less than 19 years. * Patients diagnosed with hepatoblastoma. Exclusion Criteria: * Patients whose age more than 18 years.
Where this trial is running
Assiut
- Assiut University — Assiut, Egypt (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.